デジタル糖尿病管理市場レポート：2030年までの動向、予測、競合分析

デジタル糖尿病管理の動向と予測

世界のデジタル糖尿病管理市場は、2024年から2030年までのCAGRが10.8%で、2030年までに推定310億米ドルに達すると予測されます。この市場の主な促進要因は、糖尿病有病率の増加、技術の進歩、糖尿病管理のためのクラウドベースの企業ソリューションの採用拡大です。世界のデジタル糖尿病管理市場の将来性は、病院、在宅環境、診断センター市場におけるビジネスチャンスによって有望視されています。

デジタル糖尿病管理市場の洞察

Lucintelの予測では、糖尿病管理のためのスマートインスリンポンプと自己インスリン投与用インスリンパッチの採用が拡大しているため、予測期間中もウェアラブルデバイスがより大きなセグメントであり続ける。

この市場の中で、病院は、遠隔患者モニタリングのためのデジタル技術の採用が増加しており、病院内で高度なデジタル糖尿病管理ツールが容易に利用できることから、最大のセグメントであり続けると予測しています。

北米は、コネクテッド糖尿病管理デバイスの需要増加、糖尿病管理・肥満アプリの採用急増、同地域における自己糖尿病管理に対する意識の高まりにより、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のデジタル糖尿病管理市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のデジタル糖尿病管理市場動向（2018-2023）と予測（2024-2030）
• 製品別の世界のデジタル糖尿病管理市場
  • スマート血糖計
  • 持続血糖測定システム
  • スマートインスリンペン
  • スマートインスリンポンプ
  • アプリ
• タイプ別の世界のデジタル糖尿病管理市場
  • ウェアラブルデバイス
  • ハンドヘルドデバイス
• 最終用途別の世界のデジタル糖尿病管理市場
  • 病院
  • ホーム設定
  • 診断センター

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のデジタル糖尿病管理市場
• 北米のデジタル糖尿病管理市場
• 欧州のデジタル糖尿病管理市場
• アジア太平洋デジタル糖尿病管理市場
• その他地域デジタル糖尿病管理市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界のデジタル糖尿病管理市場の成長機会
  • タイプ別の世界のデジタル糖尿病管理市場の成長機会
  • 最終用途別の世界のデジタル糖尿病管理市場の成長機会
  • 地域別の世界のデジタル糖尿病管理市場の成長機会
• 世界のデジタル糖尿病管理市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のデジタル糖尿病管理市場の能力拡大
  • 世界のデジタル糖尿病管理市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management Trends and Forecast

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

A more than 150-page report is developed to help in your business decisions.

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management by product, type, end use, and region

Digital Diabetes Management Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management Market Insights

Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Within this market, hospitals will remain the largest segment due to increasing adoption of digital technologies for remote patient monitoring and easy availability of advanced digital diabetes management tools in hospitals.

North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the digital diabetes management market size?

Answer: The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030.

Q.2 What is the growth forecast for digital diabetes management market?

Answer: The global digital diabetes management market is expected to grow with a CAGR of 10.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the digital diabetes management market?

Answer: The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

Q4. What are the major segments for digital diabetes management market?

Answer: The future of the digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets.

Q5. Who are the key digital diabetes management market companies?

Answer: Some of the key digital diabetes management companies are as follows:

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Q6. Which digital diabetes management market segment will be the largest in future?

Answer: Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Q7. In digital diabetes management market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps ), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Digital Diabetes Management Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Digital Diabetes Management Market by Product
  • 3.3.1: Smart Glucose Meter
  • 3.3.2: Continuous Blood Glucose Monitoring System
  • 3.3.3: Smart Insulin Pens
  • 3.3.4: Smart Insulin Pumps
  • 3.3.5: Apps
• 3.4: Global Digital Diabetes Management Market by Type
  • 3.4.1: Wearable Devices
  • 3.4.2: Handheld Devices
• 3.5: Global Digital Diabetes Management Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Home settings
  • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Digital Diabetes Management Market by Region
• 4.2: North American Digital Diabetes Management Market
  • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.3: European Digital Diabetes Management Market
  • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.4: APAC Digital Diabetes Management Market
  • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.5: ROW Digital Diabetes Management Market
  • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
  • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
  • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
  • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
• 6.2: Emerging Trends in the Global Digital Diabetes Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: F. Hoffmann-La Roche
• 7.4: Bayer
• 7.5: Lifescan
• 7.6: Dexcom
• 7.7: Sanofi
• 7.8: Insulet Corporation
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: B Braun Melsungen